Albarico, Jean Irish .
HRN: 26-67-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2025
MUPIROCIN 2%, 15G (TUBE)
04/18/2025
04/25/2025
TOPICAL
15g
BID
SP CS With Oophorocystectomy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes